Although the majority of LAC countries have access to brain magnetic resonance imaging (MRI) to aid in the diagnosis of AD, few cities in LAC have access to brain imaging using positron emission tomography (PET) with amyloid or tau tracers (2), recommended in the diagnostic work-up of AD (6). The gene discussed is MAPT; the disease is Alzheimer disease.